Company Filing History:
3 out of 97 
3 out of 1,147 Years Active: 2019-2020
Title: Innovations of Jun Dong Wei in Pharmaceutical Development
Introduction
Jun Dong Wei is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating inflammatory diseases. With a total of three patents to his name, his work is recognized for its potential impact on health and medicine.
Latest Patents
One of Jun Dong Wei's latest patents involves a compound that exhibits leukotriene B4 receptor 2 (BLT2) inhibitory activity. This compound is part of a pharmaceutical composition designed for preventing or treating inflammatory diseases. The invention highlights the novel compound's effectiveness in enhancing cancer cell death, inhibiting metastasis and chemotactic mobility, and demonstrating anti-asthma activity. This innovative compound holds promise as a highly effective pharmaceutical component for addressing inflammatory-related diseases.
Career Highlights
Throughout his career, Jun Dong Wei has been associated with notable institutions such as Dongguk University Industry-Academic Cooperation Foundation and Korea University Research and Business Foundation. His work in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Jun Dong Wei has collaborated with esteemed colleagues, including Yongseok Choi and Jae-Hong Kim. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the quality of his research.
Conclusion
Jun Dong Wei's innovative work in developing pharmaceutical compounds showcases his dedication to improving health outcomes. His contributions to the field of inflammatory disease treatment are noteworthy and reflect his commitment to scientific advancement.